These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12910062)

  • 41. Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them.
    Lansang MC; Hustak LK
    Cleve Clin J Med; 2011 Nov; 78(11):748-56. PubMed ID: 22049542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Commentary: Exogenous glucocorticoids influence adrenal function, but assessment can be difficult.
    Hindmarsh P
    BMJ; 2002 May; 324(7345):1083. PubMed ID: 11993494
    [No Abstract]   [Full Text] [Related]  

  • 43. The measurement of corticosteroid induced dermal atrophy by a radiological method.
    Marks R; Dykes PJ; Roberts E
    Arch Dermatol Res (1975); 1975 Sep; 253(2):93-6. PubMed ID: 1190837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of repeat doses of antenatal corticosteroids on maternal adrenal function.
    McKenna DS; Wittber GM; Nagaraja HN; Samuels P
    Am J Obstet Gynecol; 2000 Sep; 183(3):669-73. PubMed ID: 10992191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adrenal insufficiency after treatment with fluticasone. Lowest possible dose of inhaled glucocorticoids should be given.
    Patel L; Clayton PE
    BMJ; 2002 Oct; 325(7368):836; author reply 836. PubMed ID: 12378733
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis.
    Roberts DT
    Cutis; 1996 Feb; 57(2 Suppl):27-31. PubMed ID: 8646866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Majocchi's granuloma (due to therapy with steroid and occlusion).
    Jacobs PH
    Cutis; 1986 Jul; 38(1):23. PubMed ID: 3731863
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of fluconazole in a case of rapid onset ritonavir and inhaled fluticasone-associated secondary adrenal insufficiency.
    St Clair K; Maguire JD
    Int J STD AIDS; 2012 May; 23(5):371-2. PubMed ID: 22648897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (Lotrisone cream).
    Barkey WF
    J Am Acad Dermatol; 1987 Sep; 17(3):518-9. PubMed ID: 3655035
    [No Abstract]   [Full Text] [Related]  

  • 50. Glaucoma from topical corticosteroids to the eyelids.
    Garrott HM; Walland MJ
    Clin Exp Ophthalmol; 2004 Apr; 32(2):224-6. PubMed ID: 15068445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Increased risk of adrenal cortex failure after treatment of allergic rhinitis].
    Rolandsson O
    Lakartidningen; 1996 Jul; 93(28-29):2564. PubMed ID: 8801405
    [No Abstract]   [Full Text] [Related]  

  • 52. [Results of treatment and adrenal cortex function in patients with bronchial asthma after long-term use of depot betamethasone].
    Droszcz W; Piotrowska B
    Pol Arch Med Wewn; 1984 Dec; 72(6):287-91. PubMed ID: 6535149
    [No Abstract]   [Full Text] [Related]  

  • 53. Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children.
    Zöllner EW; Lombard CJ; Galal U; Hough FS; Irusen EM; Weinberg E
    Pediatrics; 2012 Dec; 130(6):e1512-9. PubMed ID: 23147980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.
    Fleming C; Ganslandt C; Leese GP
    J Drugs Dermatol; 2010 Aug; 9(8):969-74. PubMed ID: 20684147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adrenal insufficiency after treatment with fluticasone. Dose-response curve should have been highlighted.
    Mohamed ASh
    BMJ; 2002 Oct; 325(7368):836; author reply 836. PubMed ID: 12378732
    [No Abstract]   [Full Text] [Related]  

  • 56. Hyperkeratosis lenticularis perstans (Flegel's disease) - successful treatment with topical corticosteroids.
    Sterneberg-Vos H; van Marion AM; Frank J; Poblete-Gutierrez P
    Int J Dermatol; 2008 Nov; 47 Suppl 1():38-41. PubMed ID: 18986485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High risk of adrenal insufficiency after a single articular steroid injection in athletes.
    Duclos M; Guinot M; Colsy M; Merle F; Baudot C; Corcuff JB; Lebouc Y
    Med Sci Sports Exerc; 2007 Jul; 39(7):1036-43. PubMed ID: 17596769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of the safety, tolerability, and efficacy of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of eczema.
    Delescluse J; van der Endt JD
    Cutis; 1996 Feb; 57(2 Suppl):32-8. PubMed ID: 8646867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measuring adrenal function in out-patients using topical corticosteroids.
    Sparkes CG
    Br J Dermatol; 1976 Mar; 94 suppl 12():77-82. PubMed ID: 1268080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.